Journal of Medical GeneticsGeneticsPeer-reviewed journal article
Data-driven modelling of mutational hotspots and in-silico predictors in hypertrophic cardiomyopathy
Adam WaringiD, Andrew Robert HarperiD, Silvia SalatinoiD, Christopher M. KrameriD, Stefan NeubaueriD, Kate L. ThomsoniD, Hugh C WatkinsiD, Martin FarralliD
Abstract
BackgroundAlthough rare-missense variants in Mendelian disease-genes have been noted to cluster in specific regions of proteins, it is not clear how to consider this information when evaluating the pathogenicity of a gene or variant. Here we introduce methods for gene-association and variant-interpretation that utilise this powerful signal. MethodsWe present a case-control rare-variant association test, ClusterBurden, that combines information on both variant-burden and variant-clustering. We then introduce a data-driven modelling framework to estimate mutational hotspots in genes with missense variant-clustering and integrate further in-silico predictors into the models. ResultsWe show that ClusterBurden can increase statistical power to scan for putative disease-genes, driven by missense variants, in simulated data and a 34-gene panel dataset of 5,338 cases of hypertrophic cardiomyopathy. We demonstrate that data-driven models can allow quantitative application of the ACMG criteria PM1 and PP3, to resolve a wide range of pathogenicity potential amongst variants of uncertain significance. A web application (Pathogenicity_by_Position) is accessible for missense variant risk prediction of six sarcomeric genes and an R package is available for association testing using ClusterBurden. ConclusionThe inclusion of missense residue position enhances the power of disease-gene association and improves rare-variant pathogenicity interpretation.
- organism: human
- assay: DNA methylation
- assay: whole-exome sequencing
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 9
- FWCI
- 0.44
- Field percentile
- top 41%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A genome-first approach to rare variants in hypertrophic cardiomyopathy genes MYBPC3 and MYH7 in a medical biobank
Joseph Park, Elizabeth Packard, … Daniel James Rader·Human Molecular GeneticsPeer-reviewed·Sep 16, 2021
- Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: The case of hypertrophic cardiomyopathy
Roddy Walsh, Francesco Mazzarotto, … James S. Ware·Genome MedicinePeer-reviewed·Jan 29, 2019
- Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions
Xiaolei Zhang, Roddy Walsh, … James S. Ware·Genetics in MedicinePeer-reviewed·Oct 12, 2020
- Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Roddy Walsh, Kate Thomson, … Hugh C Watkins·Genetics in MedicinePeer-reviewed·Feb 1, 2017
- Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes amongst UK Biobank participants
Antonio de Marvao, Kathryn A. McGurk, … Declan P. O’Regan·Journal of the American College of CardiologyPeer-reviewed·Sep 1, 2021
- Thermodynamic destabilization informs pathogenicity assessment of a variant of uncertain significance in cardiac myosin binding protein C
María Rosaria Pricolo, Elías Herrero‐Galán, … Giulia Frisso·Journal of Cardiovascular Translational ResearchPeer-reviewed·Feb 7, 2020